Trial Profile
Efficacy of an everolimus-eluting stent vs a sirolimus-eluting stent in dialysis patients with coronary artery disease who underwent PCI
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2011
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
- 07 Sep 2011 New trial record
- 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.